August 8, 2014 / 11:02 AM / in 3 years

BUZZ-Tekmira Pharmaceuticals Corp: FDA modifies hold on Ebola drug

** Canadian biotechnology company’s U.S.-listed shares up 18.4 pct at $16.90 premarket

** FDA said on Thursday it modified clinical hold on company’s experimental Ebola drug from “full” to “partial” - to enable its potential use in humans infected with virus

** Recent Ebola outbreak has killed nearly 1,000 people in West Africa

** Tekmira’s Ebola drug is one of three drugs worldwide that have shown promising results in monkeys, but effect of these drugs is unproven in humans

** Up to Thursday’s close, Tekmira’s Nasdaq-listed stock has risen 26 pct since May 27, a day after Sierra Leone first confirmed Ebola outbreak

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below